{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:10:40Z","timestamp":1791497440521,"version":"4.3.4"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1097\/01.pas.0000173238.17331.6b","type":"journal-article","created":{"date-parts":[[2005,9,13]],"date-time":"2005-09-13T04:09:29Z","timestamp":1126584569000},"page":"1284-1293","source":"Crossref","is-referenced-by-count":119,"title":["Clinicopathologic and Prognostic Significance of Cytotoxic Molecule Expression in Nodal Peripheral T-Cell Lymphoma, Unspecified"],"prefix":"10.1097","volume":"29","author":[{"given":"Naoko","family":"Asano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitoyo","family":"Kagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Fukutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkins lymphomas: distributions of the major subtypes differ by geographic locations.","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol"},{"key":"R2-3-20210130","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4049\/jimmunol.144.2.574","article-title":"A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes.","volume":"144","author":"Anderson","year":"1990","journal-title":"J Immunol"},{"key":"R3-3-20210130","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.1997.15.6.2296","article-title":"Predictive capacity of the international prognostic factor index in patients with peripheral T-cell lymphoma.","volume":"15","author":"Ansell","year":"1997","journal-title":"J Clin Oncol"},{"key":"R4-3-20210130","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkins lymphomas: clinical features of the major histologic subtypes.","volume":"16","author":"Armitage","year":"1998","journal-title":"J Clin Oncol"},{"key":"R5-3-20210130","first-page":"1723","article-title":"Nonhepatosplenic T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization.","volume":"91","author":"Arnulf","year":"1998","journal-title":"Blood"},{"key":"R6-3-20210130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/1042819021000030054","article-title":"Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification.","volume":"44","author":"Arrowsmith","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"R7-3-20210130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1023\/A:1008200307625","article-title":"Peripheral T-cell lymphomas: clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. classification.","volume":"8","author":"Ascani","year":"1997","journal-title":"Ann Oncol"},{"key":"R8-3-20210130","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00000478-200312000-00003","article-title":"Peripheral T-cell lymphomas expressing CD30 and CD15.","volume":"27","author":"Barry","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R9-3-20210130","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood-2002-07-1960","article-title":"Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients.","volume":"102","author":"Bekkenk","year":"2003","journal-title":"Blood"},{"key":"R10-3-20210130","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients.","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"R11-3-20210130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)65144-9","article-title":"Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas: a distinct clinicopathological entity with an aggressive clinical behavior.","volume":"155","author":"Berti","year":"1999","journal-title":"Am J Pathol"},{"key":"R12-3-20210130","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1182\/blood-2004-03-1037","article-title":"Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling.","volume":"104","author":"Bonzheim","year":"2004","journal-title":"Blood"},{"key":"R13-3-20210130","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<432::AID-PATH942>3.0.CO;2-4","article-title":"Cytotoxic protein expression in natural killer cell lymphomas and in and peripheral T-cell lymphomas.","volume":"183","author":"Boulland","year":"1997","journal-title":"J Pathol"},{"key":"R14-3-20210130","first-page":"457","article-title":"Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody.","volume":"67","author":"Brousset","year":"1992","journal-title":"Lab Invest"},{"key":"R15-3-20210130","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood.V89.12.4501","article-title":"Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.","volume":"89","author":"Chan","year":"1997","journal-title":"Blood"},{"key":"R16-3-20210130","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/(SICI)1097-0215(19971104)73:3<332::AID-IJC5>3.0.CO;2-0","article-title":"Nasal T\/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.","volume":"73","author":"Chiang","year":"1997","journal-title":"Int J Cancer"},{"key":"R17-3-20210130","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0002-9440(10)65736-7","article-title":"Most CD56+ intestinal lymphomas are CD8+ CD5- T-cell lymphomas of monomorphic small to medium size histology.","volume":"153","author":"Chott","year":"1998","journal-title":"Am J Pathol"},{"key":"R18-3-20210130","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265","article-title":"Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin.","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"R19-3-20210130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1096-9896(199707)182:3<311::AID-PATH888>3.0.CO;2-U","article-title":"Expression of cytotoxic molecules in intestinal T-cell lymphomas: the German Study Group on Intestinal Non-Hodgkin Lymphoma.","volume":"182","author":"Daum","year":"1997","journal-title":"J Pathol"},{"key":"R20-3-20210130","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood.V84.11.3785.bloodjournal84113785","article-title":"Granzyme B expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization.","volume":"84","author":"De Bruin","year":"1994","journal-title":"Blood"},{"key":"R21-3-20210130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/jcp.52.2.129","article-title":"A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas.","volume":"52","author":"Dukers","year":"1999","journal-title":"J Clin Pathol"},{"key":"R22-3-20210130","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood.V87.4.1466.bloodjournal8741466","article-title":"CD5- CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas.","volume":"87","author":"Emile","year":"1996","journal-title":"Blood"},{"key":"R23-3-20210130","first-page":"1893","article-title":"TIA-1 expression in lymphoid neoplasms: identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.","volume":"150","author":"Felgar","year":"1997","journal-title":"Am J Pathol"},{"key":"R24-3-20210130","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1182\/blood.V88.10.4005.bloodjournal88104005","article-title":"Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules.","volume":"88","author":"Foss","year":"1996","journal-title":"Blood"},{"key":"R25-3-20210130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0167-5699(97)01184-5","article-title":"Lymphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases.","volume":"19","author":"Froelich","year":"1998","journal-title":"Immunol Today"},{"key":"R26-3-20210130","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study.","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"R27-3-20210130","first-page":"76","article-title":"Prognostic significance of T-cell phenotype in aggressive non-Hodgkins lymphomas.","volume":"92","author":"Gisselbrecht","year":"1998","journal-title":"Blood"},{"key":"R28-3-20210130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0167-5699(91)90145-J","article-title":"Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells.","volume":"12","author":"Griffiths","year":"1991","journal-title":"Immunol Today"},{"key":"R29-3-20210130","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International lymphoma Study Group.","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"R30-3-20210130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/1074-7613(94)90063-9","article-title":"Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules.","volume":"1","author":"Henkart","year":"1994","journal-title":"Immunity"},{"key":"R31-3-20210130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1440-1827.2003.01479.x","article-title":"Phenotypic analysis of peripheral T\/NK cell lymphoma: study of 408 Japanese cases with special reference to their anatomical states.","volume":"53","author":"Ichimura","year":"2003","journal-title":"Pathol Int"},{"key":"R32-3-20210130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/07357908409040316","article-title":"Pathologic and clinical spectrum of post-thymic T-cell malignancies.","volume":"2","author":"Jaffe","year":"1984","journal-title":"Cancer Invest"},{"issue":"suppl 2","key":"R34-3-20210130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/annonc\/8.suppl_2.S17","article-title":"Classification of T-cell and NK-cell neoplasms based on the REAL classification.","volume":"8","author":"Jaffe","year":"1997","journal-title":"Ann Oncol"},{"key":"R35-3-20210130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0037-1963(03)00132-X","article-title":"Classification of cytotoxic T-cell and natural killer cell lymphomas.","volume":"40","author":"Jaffe","year":"2003","journal-title":"Semin Hematol"},{"key":"R36-3-20210130","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/00000478-199910000-00003","article-title":"Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.","volume":"23","author":"Kagami","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"R37-3-20210130","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0002-9440(10)64114-4","article-title":"Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas.","volume":"158","author":"Kamarashev","year":"2001","journal-title":"Am J Pathol"},{"key":"R38-3-20210130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0959-8049(01)00344-6","article-title":"Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the revised European-American lymphoma (REAL) classification.","volume":"38","author":"Kim","year":"2002","journal-title":"Eur J Cancer"},{"key":"R39-3-20210130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1365-2559.2001.01058.x","article-title":"Peripheral T\/NK-cell lymphoma: a report of the IXth Workshop of the European Association for Haematopathology.","volume":"38","author":"Kluin","year":"2001","journal-title":"Histopathology"},{"key":"R40-3-20210130","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<806::AID-CNCR26>3.0.CO;2-V","article-title":"Revised European-American lymphoma: REAL classification of malignant lymphomas in the Republic of Korea.","volume":"83","author":"Ko","year":"1998","journal-title":"Cancer"},{"key":"R41-3-20210130","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1182\/blood-2002-09-2908","article-title":"The serine protease granzyme M is preferentially expressed in NK-cell, T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity.","volume":"101","author":"Krenacs","year":"2003","journal-title":"Blood"},{"key":"R42-3-20210130","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1182\/blood.V89.3.980","article-title":"Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkins disease: evidence for distinct cellular origin.","volume":"89","author":"Krenacs","year":"1997","journal-title":"Blood"},{"key":"R43-3-20210130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0046-8177(98)90122-8","article-title":"Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T-lymphocytes.","volume":"29","author":"Kumar","year":"1998","journal-title":"Hum Pathol"},{"key":"R44-3-20210130","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1008418727472","article-title":"Peripheral T-cell lymphomas: initial features, natural history and prognostic factors in a series of 174 patients diagnosed according to the REAL classification.","volume":"9","author":"Lopez-Guillermo","year":"1998","journal-title":"Ann Oncol"},{"key":"R45-3-20210130","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1440-1827.2000.01108.x","article-title":"The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities.","volume":"50","year":"2000","journal-title":"Pathol Int"},{"key":"R46-3-20210130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","article-title":"Hepatosplenic T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic T-cell lymphomas.","volume":"25","author":"Macon","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R47-3-20210130","first-page":"1085","article-title":"Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkins lymphoma.","volume":"5","author":"Moller","year":"1999","journal-title":"Clin Cancer Res"},{"key":"R48-3-20210130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2559.1993.tb00128.x","article-title":"Peripheral T-cell lymphoma: a clinicopathological study of 41 cases and evaluation of the prognostic significance of the updated Kiel classification.","volume":"22","author":"Montalban","year":"1993","journal-title":"Histopathology"},{"key":"R49-3-20210130","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1097\/00000478-199712000-00004","article-title":"Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80NPM\/ALK expression.","volume":"21","author":"Nakamura","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R50-3-20210130","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2141.2003.04668.x","article-title":"Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma.","volume":"123","author":"Niitsu","year":"2003","journal-title":"Br J Haematol"},{"key":"R51-3-20210130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/path.945","article-title":"p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome.","volume":"195","author":"Pescarmona","year":"2001","journal-title":"J Pathol"},{"key":"R53-3-20210130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0625.1992.tb00069.x","article-title":"T-cell receptor gamma delta-positive peripheral T-cell lymphomas presenting in the skin: a clinical, histological and immunophenotypic study.","volume":"1","author":"Ralfkaier","year":"1992","journal-title":"Exp Dermatol"},{"key":"R54-3-20210130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","article-title":"Non-Hodgkins Lymphoma Classification Project. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkins Lymphoma Classification Project.","volume":"13","author":"Rudiger","year":"2002","journal-title":"Ann Oncol"},{"key":"R55-3-20210130","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0046-8177(97)90176-3","article-title":"Hepatosplenic gammadelta T-cell lymphoma: ultrastractural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation.","volume":"28","author":"Salhany","year":"1997","journal-title":"Hum Pathol"},{"key":"R56-3-20210130","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/00000478-199807000-00010","article-title":"Subcutaneous panniculitis like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha\/beta and gamma\/delta subtypes.","volume":"22","author":"Salhany","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R57-3-20210130","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/cncr.11107","article-title":"Cytotoxic\/natural killer cell cutaneous lymphomas: report of EORTC Cutaneous Lymphoma Task Force Workshop.","volume":"97","author":"Santucci","year":"2003","journal-title":"Cancer"},{"key":"R58-3-20210130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0167-5699(95)80122-7","article-title":"Granzymes: exogenous proteinases that induce target cell apoptosis.","volume":"16","author":"Smyth","year":"1995","journal-title":"Immunol Today"},{"key":"R59-3-20210130","first-page":"2993","article-title":"Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T\/null cell phenotype.","volume":"96","author":"Suzuki","year":"2000","journal-title":"Blood"},{"key":"R60-3-20210130","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1182\/blood.V83.8.2255.2255","article-title":"Expression of adult and fetal natural killer cell markers in sinonasal lymphomas.","volume":"83","author":"Suzumiya","year":"1994","journal-title":"Blood"},{"key":"R61-3-20210130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0092-8674(91)90536-8","article-title":"A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells.","volume":"67","author":"Tian","year":"1991","journal-title":"Cell"},{"key":"R62-3-20210130","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archderm.136.8.1024","article-title":"T-cell lymphoma of the skin: a clinical, microscopic, and molecular study.","volume":"136","author":"Toro","year":"2000","journal-title":"Arch Dermatol"},{"key":"R63-3-20210130","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma.","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"key":"R64-3-20210130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood-2002-05-1352","article-title":"Th1, Th2 and activated T-cell marker, and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma and ATLL.","volume":"103","author":"Tsuchiya","year":"2004","journal-title":"Blood"},{"key":"R65-3-20210130","first-page":"313","article-title":"Perforin and granzyme expression in cytotoxic T-cell lymphomas.","volume":"11","author":"Yamashita","year":"1998","journal-title":"Mod Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.pas.0000173238.17331.6b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:56:26Z","timestamp":1785855386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000478-200510000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.pas.0000173238.17331.6b","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}